Healthequity Inc (HQY) Shares Sold by Columbus Circle Investors

Columbus Circle Investors cut its stake in shares of Healthequity Inc (NASDAQ:HQY) by 4.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 158,886 shares of the company’s stock after selling 6,727 shares during the quarter. Columbus Circle Investors’ holdings in Healthequity were worth $15,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently made changes to their positions in HQY. State Treasurer State of Michigan bought a new stake in shares of Healthequity in the 3rd quarter worth approximately $1,888,000. Sawtooth Solutions LLC lifted its holdings in shares of Healthequity by 71.3% in the 3rd quarter. Sawtooth Solutions LLC now owns 4,738 shares of the company’s stock worth $448,000 after acquiring an additional 1,972 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of Healthequity by 64.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 24,302 shares of the company’s stock worth $2,294,000 after acquiring an additional 9,562 shares during the last quarter. Securian Asset Management Inc bought a new stake in shares of Healthequity in the 3rd quarter worth approximately $626,000. Finally, First Trust Advisors LP lifted its holdings in shares of Healthequity by 7.7% in the 3rd quarter. First Trust Advisors LP now owns 133,036 shares of the company’s stock worth $12,560,000 after acquiring an additional 9,508 shares during the last quarter. Institutional investors and hedge funds own 96.89% of the company’s stock.

Shares of NASDAQ HQY opened at $87.52 on Wednesday. Healthequity Inc has a 52 week low of $42.92 and a 52 week high of $99.99. The firm has a market capitalization of $5.29 billion, a P/E ratio of 110.30, a PEG ratio of 2.95 and a beta of 1.47.



Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 4th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.22 by $0.12. Healthequity had a net margin of 23.81% and a return on equity of 12.58%. The company had revenue of $71.10 million for the quarter, compared to the consensus estimate of $69.84 million. During the same period in the previous year, the firm earned $0.27 earnings per share. The firm’s revenue for the quarter was up 25.0% on a year-over-year basis. As a group, analysts anticipate that Healthequity Inc will post 0.87 EPS for the current year.

HQY has been the topic of several analyst reports. Raymond James lifted their target price on shares of Healthequity from $85.00 to $105.00 and gave the stock an “outperform” rating in a research note on Monday, September 10th. Bank of America downgraded shares of Healthequity from a “buy” rating to a “neutral” rating and lifted their target price for the stock from $84.00 to $105.00 in a research note on Thursday, September 6th. They noted that the move was a valuation call. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Healthequity in a research note on Wednesday, September 5th. They noted that the move was a valuation call. SunTrust Banks lifted their target price on shares of Healthequity to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, September 5th. Finally, Wells Fargo & Co lifted their target price on shares of Healthequity from $84.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 5th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $93.08.

In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction on Monday, August 20th. The shares were sold at an average price of $86.37, for a total transaction of $345,480.00. Following the transaction, the vice president now directly owns 99,200 shares of the company’s stock, valued at approximately $8,567,904. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last ninety days, insiders sold 12,000 shares of company stock worth $1,065,240. 4.00% of the stock is owned by insiders.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More: What is the 52-week high/low?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply